1. Definitions of the MetS by the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria
Wang J, et al. Eur Heart J 2007;28:857-64

2. Baseline characteristics of subjects who died of CHD, CVD or any cause, and risk factors for CHD, CVD, and all-cause mortality during the 13-year follow-up in 1025 non-diabetic subjects (univariable Cox regression analysis)
Wang J, et al. Eur Heart J 2007;28:857-64

3. HRs and their 95% CI (in parentheses) of the MetS defined by the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria for CHD, CVD, and all-cause mortality during the 13-year follow-up in non-diabetic subjects (percentage in parentheses after each definition is the prevalence of the MetS)
Wang J, et al. Eur Heart J 2007;28:857-64

4. HRs of the MetS defined by the WHO, EGIR, NCEP, ACE, IDF and updated NCEP criteria for CHD, CVD, and all-cause mortality during the 13-year follow-up in 377 non-diabetic men and 648 non-diabetic women
Wang J, et al. Eur Heart J 2007;28:857-64

5. HRs of individual components of the MetS for CVD
mortality based on the WHO, EGIR, NCEP, ACE, IDF, and updated NCEP criteria in 1025 non-diabetic subjects
Wang J, et al. Eur Heart J 2007;28:857-64